TITLE

CNS News Round-Up

PUB. DATE
October 2003
SOURCE
PharmaWatch: CNS;October 2003, Vol. 2 Issue 10, p2
SOURCE TYPE
Market Research Report
DOC. TYPE
Article
ABSTRACT
Reports on developments related to the pharmaceutical industry as of October 2003. Move of Novartis AG to license Cytos Biotechnology's Immunodrugs against Alzheimer's disease; Approval from the U.S. Food and Drug Administration granted to GlaxoSmithKline PLC to expand the indications of Paxil and Wellbutrin; Launch of the first generic version of GlaxoSmithKline's top-selling Paxil in the U.S. by Apotex Inc.
ACCESSION #
13863589

 

Related Articles

  • Psychiatry News Headlines August 15, 2003 - September 14, 2003.  // PharmaWatch: CNS;October 2003, Vol. 2 Issue 10, p10 

    Reports on developments related to the management of psychiatric disorders as of October 2003. Approval granted by the U.S. Food and Drug Administration on the dosage of an antidepressant formulation from GlaxoSmithKline PLC; Launch of the first generic version of Paxil by Apotex Inc.; Benefits...

  • Pipeline.  // Medical Marketing & Media;Sep2009, Vol. 44 Issue 9, p12 

    The article offers news briefs related to drug approvals from the U.S. Food and Drug Administration. The Hiberix, a booster shot for children 15 months to four years of age, of GlaxoSmithKline has received approval. An approval for Embeda, a schedule II opioid analgesic for moderate to severe...

  • First-time generic approvals.  // Formulary;Feb2004, Vol. 39 Issue 2, p80 

    Presents first-time generic approvals by the U.S. Food and Drug Administration as of February 2004. Fenoldopam injection; Amiodarone tablets; Amoxicillin tablets; Others.

  • Pipeline.  // Medical Marketing & Media;Aug2006, Vol. 41 Issue 8, p12 

    The article reports developments related to pharmaceutical industry. GlaxoSmithKline PLC has announced that the Food and Drug Administration (FDA) approved its Avandamet drug for use in initial treatment of type 2 diabetes. Wyeth Inc. has received an approvable letter for its oral contraceptive...

  • Latebreakers.  // Drug Topics;10/13/2008, Vol. 152 Issue 11, p8 

    The article offers news briefs from the U.S. pharmaceutical industry. The Food and Drug Administration (FDA) announced the approval of the types 16 and 18 Gardasil vaccines for the prevention of vaginal and vulvar cancer caused by human papillomavirus (HPV). Walgreens has reopened its store in...

  • A bitter pill. Goetzl, David // Advertising Age;8/6/2001, Vol. 72 Issue 32, p3 

    The article reports on the impact of the United States Food and Drug Administration's (FDA) decision not to approve Novartis Corp.'s Zelnorm drug, which was designed to treat irritable bowel syndrome, on the pharmaceutical company's reputation and financial status. The drug would have generated...

  • Novartis receives nod for Exjade.  // Drug Topics;11/21/2005, Vol. 149 Issue 22, p10 

    This article reports that the U.S. Food and Drug Administration has approved Novartis AG's Exjade or deferasirox, the first and only once-daily oral iron chelator. Deferasirox has been approved for the treatment of chronic iron overload due to blood transfusion in adults and children who are two...

  • FDA OKs First Biosimilar Drug, Knockoff Of Amgen's Neupogen. AMY REEVES // Investors Business Daily;3/6/2015, p00 

    The article reports on the drug approval of the U.S. Food & Drug Administration (FDA) on Zarxio from the Swiss pharmaceutical company Novartis. It states that the drug was a biosimilar of Neupogen drug from the biopharmaceutical company Amgen. It also mentions that Zarxio had a similar drug...

  • NEWSLINE.  // MPR - Pharmacist's Edition;Winter2015/2016, Vol. 9 Issue 4, pA5 

    This section offers news briefs related to the pharmaceutical industry in the U.S. Topics discussed include an approval granted by the U.S. Food and Drug Administration (FDA) to Nucala for injection as add-on maintenance treatment in patients with severe asthma, and an FDA approval for Novartis'...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics